Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment
Gregor Werba, Daniel Weissinger, Emily Kawaler, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
The nuclear factor ID3 endows macrophages with a potent anti-tumour activity
Zihou Deng, Pierre-Louis Loyher, Tomi Lazarov, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 864-873
Open Access | Times Cited: 23
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer
Jason M. Link, Jennifer Eng, Carl Pelz, et al.
Nature Cancer (2025)
Open Access | Times Cited: 2
Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer
Suhail Yousuf, Mengjie Qiu, Lena Voith von Voithenberg, et al.
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 891-908.e14
Open Access | Times Cited: 41
Escape from T-cell–targeting immunotherapies in acute myeloid leukemia
Jayakumar Vadakekolathu, Sergio Rutella
Blood (2023) Vol. 143, Iss. 26, pp. 2689-2700
Open Access | Times Cited: 30
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Xu Zhou, Jingyu An, Roma Kurilov, et al.
Nature Cancer (2023) Vol. 4, Iss. 9, pp. 1362-1381
Open Access | Times Cited: 29
Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer
Xiameng Gai, Yingluo Liu, Xiaojing Lan, et al.
Cancer Research (2024) Vol. 84, Iss. 12, pp. 1963-1977
Closed Access | Times Cited: 14
Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome
Gabriela Rapozo Guimarães, Giovanna Resk Maklouf, Cristiane Esteves Teixeira, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer
Veronica Ruta, Chiara Naro, Marco Pieraccioli, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101411-101411
Open Access | Times Cited: 11
Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response
Chen Lior, Debra Barki, Coral Halperin, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114236-114236
Open Access | Times Cited: 11
Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance
Anastasia N. Kazakova, Maria M. Lukina, Ksenia S. Anufrieva, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
Emerging clinical applications of single-cell RNA sequencing in oncology
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
Marc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 12, pp. 1129-1142
Closed Access | Times Cited: 22
Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma
Ann Mary Joseph, Ahmad Al Aiyan, Basel K. al-Ramadi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Julianne M. Szczepanski, Mark A. Rudolf, Jiaqi Shi
Cancers (2024) Vol. 16, Iss. 4, pp. 794-794
Open Access | Times Cited: 7
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer
Yifan Fu, Jinxin Tao, Tao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors
Ankit Dahal, Yeonsun Hong, Jocelyn S. Mathew, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 35
Closed Access | Times Cited: 6
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer
Maxim Le Compte, Edgar Cardenas De La Hoz, Sofía Peeters, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 15
Single-Cell Informatics for Tumor Microenvironment and Immunotherapy
Jiabao Tian, Xinyu Bai, Camelia Quek
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4485-4485
Open Access | Times Cited: 5
Dynamic Immunoediting by Macrophages in Homologous Recombination Deficiency-Stratified Pancreatic Ductal Adenocarcinoma
Weifeng Hong, Feng Zhang, Nan Wang, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101115-101115
Closed Access | Times Cited: 5
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
Paul E. Oberstein, Andressa Dias Costa, Emily Kawaler, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 9, pp. 1221-1235
Closed Access | Times Cited: 5
Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma
Haizhen Luo, Naoki Ikenaga, Kohei Nakata, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma
Aristeidis Papargyriou, Mulham Najajreh, David P. Cook, et al.
Nature Biomedical Engineering (2024)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top